Structural and neurochemical markers of brain injury in the migraine diathesis of systemic lupus erythematosus. (Q48439095)

11 February 2018

title

Structural and neurochemical markers of brain injury in the migraine diathesis of systemic lupus erythematosus. (English)

1 reference

11 February 2018

1 reference

3

1 reference

11 February 2018

author name string

C L Rozell

series ordinal

1

1 reference

11 February 2018

W L Sibbitt

series ordinal

2

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

11 February 2018

published in

Cephalalgia

1 reference

11 February 2018

volume

18

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

209-215

1 reference

11 February 2018

Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Headache in small vessel disease of the brain: a study of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Lupus erythematosus in the 1980s: a survey of 570 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

The neuropsychiatric manifestations of systemic lupus erythematosus: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Migrainous phenomena in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Nervous system involvement in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Diagnosis and pathogenesis of CNS lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

A study of migraine in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Migraine and the lupus anticoagulant. Case reports and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Migraine and anti-phospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Cerebral venous thrombosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Lupus meningitis. Antibody to deoxyribonucleic acid (DNA) and DNA:anti-DNA complexes in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Aseptic meningitis in systemic lupus erythematosus. Report of three cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Recurrent sterile meningitis as a manifestation of systemic lupus erythematosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Interferon-alpha in lupus psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

The prevalence of cerebral damage varies with migraine type: a MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Magnetic resonance spectroscopy studies in migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

N-acetylaspartate reductions measured by 1H MRSI in cognitively impaired HIV-seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

Subdural Hematoma Presenting as Headache in Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804209.X

10.1046/J.1468-2982.1998.1804209.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9642496

1 reference

11 February 2018